JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson

Equities

JNJ

US4781601046

Real-time Estimate Cboe BZX Other stock markets 10:13:35 2024-04-30 am EDT			5-day change	1st Jan Change
145.5 ^USD	-0.92%		-2.60%	-7.06%

Apr. 29	J&J, Bristol Myers lose challenges to US drug price negotiation program	RE
Apr. 29	J&J: positive CHMP opinion for lung cancer	CF

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	19-11-27
JOHNSON & JOHNSON :The underlying trend is to the upside	17-06-12
JOHNSON & JOHNSON :Expect the comeback of a strong trend	17-05-10
JOHNSON & JOHNSON :Buying pressure	16-12-22
JOHNSON & JOHNSON :A good level to buy	16-09-12
JOHNSON & JOHNSON :Towards historic highs	12-09-26
JOHNSON & JOHNSON :Beginning of a bearish movement	12-06-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer